by Rebecca Handler | Sep 26, 2025 | BHC News, Patient Education, Provider Education
The Next Expansion: Why Rheumatology Must Prepare for Infection-Associated Chronic Conditions (IACCs) When The Lancet Rheumatology published Dr. Brittany Adler’s essay, Expanding the Rheumatology Lens: Should We Embrace POTS and Post-Infectious Syndromes?, it captured...
by Rebecca Handler | Sep 19, 2025 | BHC News, Research News
Mitochondria in the Spotlight: From NIH Recognition to Research Advances When the National Institutes of Health (NIH) released its recent Research in Context feature on mitochondria, it did something that may have gone unnoticed by many but was profoundly significant...
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career – the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.
Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition.
In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today.
Lucinda Bateman, MD, is a renowned clinician, researcher, and educator. Her Johns Hopkins University Medical School training instilled an approach to care that she has employed throughout her career – the patient comes first and the unknown or unexplained does not equate to a lack of proper and compassionate care. Since starting her own practice in 2000, she has served on six boards or committees, been the principal investigator for 45 studies, authored/coauthored 40 journal articles, served as adjunct instructor and adjunct assistant professor in the University of Utah Departments of Preventative Medicine, Internal Medicine, and Anesthesiology, and lectured around the world.
Bateman served as a clinical expert on the 2015 IOM/NAM committee, contributing her expertise in the development of the clinical diagnostic criteria for ME/CFS, a pivotal and influential moment for all clinicians, researchers, and patients. Medical and scientific collaborations include work with Stanford, Columbia, Cornell, Harvard, CDC, NIH, RECOVER Initiative, Riken, and she is the co-founder of the U.S. ME/CFS Clinician Coalition.
In 2015 she expanded her impact by combining her private clinical and research practice with its sister non-profit, OFFER, to create a medical center of excellence, BHC, dedicated to the diagnosis, management, research, and education for the benefit of individuals impacted by msCCD. Her passion for increasing access to informed medical care fuels her focus on medical education today. Read her full bio here.
